Search research articles
Contact Us
Filters
Showing results (621-630 of 650) with videos related to
Page
of 65
Sort By:
Angewandte Chemie (International Ed. in English)
|
January 10, 2024
Vinylogous Urea-Urethane Vitrimers: Accelerating and Inhibiting Network Dynamics through Hydrogen Bonding
Stéphanie Engelen, Neil D Dolinski, Chuqiao Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 8, 2011
Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice
Wei Gu, David J Lloyd, Narumol Chinookswong, et al.
Journal of Chronic Diseases
|
January 1, 1982
Pulse pressure-III. Prognostic significance in four Chicago epidemiologic studies
A R Dyer, J Stamler, R B Shekelle, et al.
Chemical Science
|
September 19, 2025
Structure-property relationships of responsive doubly-threaded slide-ring polycatenane networks
Guancen Liu, Jongwon Oh, Yuan Tian, et al.
Science (New York, N.Y.)
|
February 1, 2024
Accessing pluripotent materials through tempering of dynamic covalent polymer networks
Nicholas R Boynton, Joseph M Dennis, Neil D Dolinski, et al.
Nature
|
April 7, 1994
B61 is a ligand for the ECK receptor protein-tyrosine kinase
T D Bartley, R W Hunt, A A Welcher, et al.
European Journal of Endocrinology
|
November 26, 2002
Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001
M B Ranke, C J Partsch, A Lindberg, et al.
Diabetes
|
June 29, 2006
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action
Varman T Samuel, Cheol Soo Choi, Trevor G Phillips, et al.
Journal of Dental Research
|
July 23, 2014
Longevity of posterior composite restorations: a systematic review and meta-analysis
N J M Opdam, F H van de Sande, E Bronkhorst, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 2, 2009
Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia
Wei Gu, Hai Yan, Katherine A Winters, et al.
Page
of 65
Search research articles
Search
Showing results (621-630 of 650) with videos related to
Sort By:
Page
of 65
Angewandte Chemie (International Ed. in English)
|
January 10, 2024
Vinylogous Urea-Urethane Vitrimers: Accelerating and Inhibiting Network Dynamics through Hydrogen Bonding
Stéphanie Engelen, Neil D Dolinski, Chuqiao Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 8, 2011
Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice
Wei Gu, David J Lloyd, Narumol Chinookswong, et al.
Journal of Chronic Diseases
|
January 1, 1982
Pulse pressure-III. Prognostic significance in four Chicago epidemiologic studies
A R Dyer, J Stamler, R B Shekelle, et al.
Chemical Science
|
September 19, 2025
Structure-property relationships of responsive doubly-threaded slide-ring polycatenane networks
Guancen Liu, Jongwon Oh, Yuan Tian, et al.
Science (New York, N.Y.)
|
February 1, 2024
Accessing pluripotent materials through tempering of dynamic covalent polymer networks
Nicholas R Boynton, Joseph M Dennis, Neil D Dolinski, et al.
Nature
|
April 7, 1994
B61 is a ligand for the ECK receptor protein-tyrosine kinase
T D Bartley, R W Hunt, A A Welcher, et al.
European Journal of Endocrinology
|
November 26, 2002
Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001
M B Ranke, C J Partsch, A Lindberg, et al.
Diabetes
|
June 29, 2006
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action
Varman T Samuel, Cheol Soo Choi, Trevor G Phillips, et al.
Journal of Dental Research
|
July 23, 2014
Longevity of posterior composite restorations: a systematic review and meta-analysis
N J M Opdam, F H van de Sande, E Bronkhorst, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 2, 2009
Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia
Wei Gu, Hai Yan, Katherine A Winters, et al.
Page
of 65